Ascentage Pharma Group International (NASDAQ:AAPG) Stock Picked Up by Analysts at Citizens Jmp

Investment analysts at Citizens Jmp started coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG) in a report released on Tuesday, Benzinga reports. The brokerage set a “market outperform” rating and a $35.00 price target on the stock. Citizens Jmp’s target price would indicate a potential upside of 127.64% from the company’s current price.

AAPG has been the subject of several other research reports. BTIG Research restated a “buy” rating and set a $48.00 price target on shares of Ascentage Pharma Group International in a research report on Friday, August 21st. JPMorgan Chase & Co. cut their price objective on shares of Ascentage Pharma Group International from $46.00 to $33.00 and set an “overweight” rating on the stock in a research report on Thursday, October 8th. Finally, Citigroup started coverage on shares of Ascentage Pharma Group International in a research report on Tuesday. They issued an “outperform” rating on the stock. Two research analysts have rated the stock with a Strong Buy rating and eleven have given a Buy rating to the company. According to data from MarketBeat, Ascentage Pharma Group International has a consensus rating of “Buy” and an average target price of $43.67.

Ascentage Pharma Group International Stock Performance

NASDAQ:AAPG opened at $15.38 on Tuesday. The business has a 50 day simple moving average of $16.68 and a 200 day simple moving average of $19.27. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.18 and a current ratio of 1.22. Ascentage Pharma Group International has a 12-month low of $14.45 and a 12-month high of $37.50.

Ascentage Pharma Group International (NASDAQ:AAPG) last issued its earnings results on Wednesday, August 19th. The company reported ($0.65) earnings per share for the quarter. The business had revenue of $22.24 million during the quarter. On average, equities analysts anticipate that Ascentage Pharma Group International will post -2.42 earnings per share for the current year.

About Ascentage Pharma Group International

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.